Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Faces Patent Infringement Suit - Business Standard

Tuesday, 5 Nov 2013 09:34am EST 

Business Standard reported that the Teijin Limited, owner of the US patent of hyperuricemia drug febuxostat, along with the two licence holders of the patent, has filed an infringement suit against Dr.Reddy's Laboratories Ltd for seeking to manufacture and sell a generic version of the drug in the US before the expiration of the patent. 

Company Quote

1.69 +3.11%
3:59pm EST